期刊文献+

低浓度5-氟尿嘧啶与糖皮质激素联合激光治疗瘢痕疙瘩的疗效 被引量:1

The therapy function of low concentration 5-Fu and steroid associate with laser to keloid
原文传递
导出
摘要 目的 观察低浓度5-氟尿嘧啶(5-Fu)与糖皮质激素局部注射联合激光治疗瘢痕疙瘩的疗效及安全性.方法 瘢痕疙瘩70例,102处病灶,平均病史8.6年,平均治疗时间为10.29个月.70例瘢痕疙瘩患者108处病灶进行单纯瘢痕内注射,0.6 ml 5-Fu与5 ml曲安奈德、1 ml 2%利多卡因混合后局部注射于瘢痕全层注射,每2~4周1次,瘢痕完全萎缩后逐渐降低药物浓度并延长注射间歇期.另一组70例瘢痕疙瘩患者102处病灶将三联药物局部注射半个月后Nd:YAG激光照射,每2~4周1次.结果 在治疗6个月以上的患者中,5-氟尿嘧啶与糖皮质激素联合激光治疗瘢痕疙瘩的总有效率为97.06%,其中完全缓解者占45.10%,极大缓解者占49.02%,部分缓解者占2.94%,未缓解者为2.94%.结论 低浓度5-氟尿嘧啶与糖皮质激素局部注射联合激光治疗瘢痕疙瘩的疗效显著. Objective To monitor the therapeutic action and security of 5-Fu and steroid injected associate with laser to keloid. Methods One hundred and two keloid focuses of 70 patients have the average 8.6 years history and the average therapy period of 10.29 months. Among them,70 patients with total 108 keloid were treated merely with intralesional injection of a mixture of 0.6 ml 5-Fu,5 ml corticosteroid and 1 ml 2% lidocaine once per 2-4 weeks. The other 70 patients with total 102 keloid around sternal area were treated with the mixture once per 2-4 weeks. And they were irradiated with apulsed Nd:YAG laser(wavelength 1064 nm)at 35-140 energy density levels after 15 days. After keloid became flattened,drug concentration was decreased with prolonged intermission of drug injection. Results The total therapy efficacy of 5-Fu associate with steroid to keloid was 97.06%. Of them, the complete remission percentage was 45.10%,the large remission percentage was 49.02%,part remission percentage was 2.94%,and the inefficacy percentage was 2.94%. Conclusions It is more effective that the combination therapy to keloid of low concentration 5-Fu,steroid and Nd:YAG laser.
出处 《中国实用医刊》 2010年第16期27-29,共3页 Chinese Journal of Practical Medicine
  • 相关文献

同被引文献16

  • 1Branski L K, Rennekampff H O, Vogt P M. Keloid and hypertrophic scar treatment modalities: an update[J]. Chirurg, 2012, 83 (9) :831-846.
  • 2Weshahy A H, Abdel Hay R. Intralesional cryosurgery and intralesional steroid injection: a good combination therapy for treatment of keloids and hypertrophic scars [J]. Dermatol Ther, 2012, 25(3) :273-276.
  • 3Halim A S, Emami A, Salahshourifar I, et al. Keloid scarring: understanding the genetic basis, advances, and prospects[J]. Arch Plast Surg, 2012, 39(3) :184-189.
  • 4Gauglitz G G, Korting H C, Pavicic T, et al. Hypertrophic scarfing and keloids: pathomechanisms and current and emerging treatment strategies [ J ]. Mol Med, 2011, 17(1-2) :113-125.
  • 5Vivante H, Salgueiro M J, Ughetti R, et al. ^32P-path contact brachyradio therapy in the management of recalcitrant keloids and hypertrophic scars [ J ]. Indian J Dermatol Venereol Leprol, 2007, 73 (5) :336-339.
  • 6Kelly A P. Update on the management of keloids [J]. Semin Cutan Med Surg, 2009, 28(2) :71-76.
  • 7Ogawa R, Akaishi S, Huang C, et al. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarfing: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction[J]. J Nippon Meal Sch, 2011, 78 (2) :68-76.
  • 8Park T H, Seo S W, Kim J K, et al. Management of chest keloids[J]. J Cardiothorac Surg, 2011, 6:49.
  • 9鲁开化,李荟元,夏炜,易成刚.病理性瘢痕防治研究的探讨[J].中国美容整形外科杂志,2010,21(4):193-197. 被引量:20
  • 10康伟明,张明谏,李敬永,徐敏.低浓度5-氟尿嘧啶与糖皮质激素联合治疗瘢痕疙瘩临床疗效Meta分析[J].天津医科大学学报,2010,16(2):285-287. 被引量:12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部